Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2007
03/22/2007WO2007031747A1 Imdolizine derivatives as ligands of the crth2 receptor
03/22/2007WO2007031529A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity
03/22/2007WO2007031338A1 Use of ligands of pparϝ for inducing foetal lung maturity and the prevention of the respiratory-distress syndrome in premature infants
03/22/2007WO2006002909A3 Sphingolipids against pathological processes in lipid rafts
03/22/2007US20070066659 Use of tenatoprazole for the treatment of gastroesophageal reflux disease
03/22/2007US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors
03/22/2007US20070066586 Aniline derivatives
03/22/2007US20070066554 Immunostimulatory nucleic acids
03/22/2007US20070066553 Immunostimulatory nucleic acid molecules
03/22/2007US20070065868 IL-17 receptor like molecules and uses thereof
03/22/2007US20070065517 Modafinil Pharmaceutical Compositions
03/22/2007US20070065485 Therapeutic delivery of carbon monoxide
03/22/2007US20070065373 Mucoactive agents for treating a pulmonary disease
03/22/2007CA2622721A1 Method and means of preventing and treating sleep disordered breathing
03/22/2007CA2622605A1 Heterocycle compound, and production process and application thereof
03/22/2007CA2622372A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity
03/22/2007CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity
03/22/2007CA2621273A1 Stable pharmaceutical composition comprising a pyrimidine-sulfamide
03/21/2007EP1764366A2 Thrombin receptor antagonists
03/21/2007EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
03/21/2007EP1764097A1 Methods and compositions for soothing oral and nasal tissues
03/21/2007EP1764096A1 Novel phloroglucinol derivatives having selectin ligand activity
03/21/2007EP1764095A1 Novel nitrocatechol derivatives having selectin ligand activity
03/21/2007EP1764094A1 Novel multi-cyclic compounds and their use
03/21/2007EP1764093A1 Novel aromatic compounds and their use in medical applications
03/21/2007EP1764091A2 Improvements in or relating to amphoteric liposomes
03/21/2007EP1764085A1 Cosmetic composition comprising argan oil
03/21/2007EP1763528A1 Pyrazolopyridine derivatives
03/21/2007EP1763369A1 Combinations comprising antimuscarinic agents and corticosteroids
03/21/2007EP1763368A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
03/21/2007EP1763361A2 Steroid sparing agents and their use
03/21/2007EP1763346A2 Compositions and methods relating to pyrimidine synthesis inhibitors
03/21/2007EP1763342A2 Sphingolipids against pathological processes in lipid rafts
03/21/2007EP1651270B1 Medicaments for inhalation comprising betamimetics and an anticholinergic
03/21/2007EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
03/21/2007EP1465607B1 Pharmaceutical formulations with modified release
03/21/2007EP1455782B1 High-concentration stable meloxicam solutions for needle-less injection
03/21/2007EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
03/21/2007EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same
03/21/2007EP1397492B1 Modified and stabilized gdf propeptides and uses thereof
03/21/2007EP1397127B1 Solid pharmaceutucal formulations comprising modafinil
03/21/2007EP1237878B1 4-pyrimidinyl-n-acyl-l-phenylalanines
03/21/2007CN1934077A 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
03/21/2007CN1934073A Novel crystal of triterpene derivative
03/21/2007CN1934068A Levalbuterol hydrochloride polymorph a
03/21/2007CN1934067A Preparation of levalbuterol hydrochloride
03/21/2007CN1933831A Use of a pyrazole derivative for producing medicaments that are useful in preventing and treating chronic bronchitis and chronic obstructive bronchopneumopathy
03/21/2007CN1931872A Casein hydrolysate and its prepn process
03/21/2007CN1931359A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1931358A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1931356A Chinese medicine for clearing away heat and toxic matter to prevent and treat common cold and the method of preparing herb tea, oral liquid and granule therewith
03/21/2007CN1931344A Medicine ointment for treating allergic rhinitis and its production process
03/21/2007CN1931341A Medicine powder for treating bronchitis and its prepn process
03/21/2007CN1931320A Medicinal wine composition and its prepn process
03/21/2007CN1931317A Winterchery fruit buccal tablet and its prepn process
03/21/2007CN1931314A Medicine and its prepn process
03/21/2007CN1931296A Pinellia tuber extract and its prepn process, medicine composition and use
03/21/2007CN1931293A Oil-in-water type nanometer grassleaved sweetflag oil emulsion oral liquid and its prepn process
03/21/2007CN1931273A Cough treating Chinese medicine plaster
03/21/2007CN1931262A Common cold treating Chinese medicine prepn
03/21/2007CN1931258A Prepn process and use of loquat seed extract
03/21/2007CN1931247A Medicine for treating rhinitis and its prepn process
03/21/2007CN1931240A Asiatic moonseed rhizome extract and its prepn and use
03/21/2007CN1931232A Oil-in-water nanometer perilla seed oil emulsion oral liquid and its prepn process
03/21/2007CN1931231A Chinese medicine gargle for treating periodontal disease and stomatocace
03/21/2007CN1931229A Medicine for treating acute and chronic nasopharyngitis and its prepn process
03/21/2007CN1931175A Medicine composition for preventing and treating farm animal's respiratory tract and digestive tract diseases
03/21/2007CN1931171A Method of making antitussive medicine and relieving cough
03/21/2007CN1931130A Nanometer emulsion oral liquid of andrographolide and its prepn process
03/21/2007CN1305899C Therapeutic peptides
03/21/2007CN1305892C Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester
03/21/2007CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
03/21/2007CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands
03/21/2007CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
03/21/2007CN1305475C Boronic ester and acid compounds, synthesis and uses
03/21/2007CN1305474C Nose cavity administering formulation of nalmefene
03/20/2007US7193108 Phenylpropionic acid derivatives
03/20/2007US7192978 Pyrrolidinium derivatives
03/20/2007US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof
03/20/2007US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/20/2007US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents
03/20/2007US7192969 Ester derivatives
03/20/2007US7192964 4-oxoimidazolidine-2-spiropiperidine derivatives
03/20/2007US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases
03/20/2007US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects
03/20/2007US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment
03/20/2007US7192960 Sodium channel blockers
03/20/2007US7192959 Sodium channel blockers
03/20/2007US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
03/20/2007US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/20/2007US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
03/20/2007US7192582 Human monoclonal antibodies to FC alpha receptor (CD89)
03/20/2007US7192578 By administering antiinflammatory drugs
03/20/2007US7192570 Compositions of somatostatin analogues
03/20/2007CA2433518C Method for producing the anticholinergic tiotropium bromide
03/15/2007WO2007030061A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
03/15/2007WO2007029847A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
03/15/2007WO2007029077A1 Substituted indazoles as inhibitors of phosphodiesterase type-iv
03/15/2007WO2007029041A2 Interferon lambda therapy for treatment of respiratory diseases
1 ... 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 ... 878